The results in breast cancer patients showed that the relatively high expression of YTHDF3 and LRPPRC were remarkably associated with worse RFS, whereas relatively high expression of RBM15B, ZC3H13, and METTL16 had better RFS (Figure 8). Here, YTHDF3 is linked to breast carcinoma.